Inigo O. E.
- Country
- Spain
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 146 partner sites.
Specializations
Hematologic Oncology
Investigator specializes in treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), focusing on innovative therapeutic approaches for previously untreated patients.
- Blood Cancer Management
- Leukemia Treatment Strategies
- Lymphoma Therapeutics
The investigator explores treatment optimization through targeted therapies and novel drug combinations.
Precision Medicine
Expertise in developing minimal residual disease (MRD)-guided treatment approaches, tailoring therapy duration based on individual patient response.
- Personalized Treatment Duration
- Response-Adapted Therapy
- Treatment Optimization
Focus on implementing adaptive treatment strategies to enhance therapeutic outcomes in blood cancers.
Novel Therapeutics
Investigates combination therapies including targeted agents for hematologic malignancies, with particular attention to fixed-duration treatment protocols.
- Combination Therapy Development
- Duration-Specific Protocols
- Treatment Innovation
Advances therapeutic strategies through evaluation of novel drug combinations and treatment durations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.